AstraZeneca’s Market Cap Soars Past £200 Billion for First Time
(Bloomberg) -- AstraZeneca Plc has become the first British company to be valued at more than £200 billion ($257 billion) after a big bet on cancer drugs helped drive a rally in the shares. Most Read from BloombergBiden Invests $100 Million to Fuel Housing ConstructionIn DNC, Chicago’s Embattled Transit System Faces a High-Profile TestJohannesburg Mayor Quits Amid Infighting, Financial WoesHow Chicago’s Gigantic Merchandise Mart Is Still Thriving as Office SpaceGottheimer Calls for Rail Riders t